Sleep Disturbance as a Therapeutic Target to Improve Opioid Use Disorder Treatment

Sleep health is an important factor across several physical and mental health disorders, and a growing scientific consensus has identified sleep as a critical component of opioid use disorder (OUD), both in the active disease state and during OUD recovery. The goal of this narrative review is to col...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental and clinical psychopharmacology 2022-12, Vol.30 (6), p.1024-1035
Hauptverfasser: Huhn, Andrew S., Finan, Patrick H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1035
container_issue 6
container_start_page 1024
container_title Experimental and clinical psychopharmacology
container_volume 30
creator Huhn, Andrew S.
Finan, Patrick H.
description Sleep health is an important factor across several physical and mental health disorders, and a growing scientific consensus has identified sleep as a critical component of opioid use disorder (OUD), both in the active disease state and during OUD recovery. The goal of this narrative review is to collate the literature on sleep, opioid use, and OUD as a means of identifying therapeutic targets to improve OUD treatment outcomes. Sleep disturbance is common and often severe in persons with OUD, especially during opioid withdrawal, but also in persons on opioid maintenance therapies. There is ample evidence that sleep disturbances including reduced total sleep time, disrupted sleep continuity, and poor sleep quality often accompany negative OUD treatment outcomes. Sleep disturbances are bidirectionally associated with several other factors related to negative treatment outcomes, including chronic stress, stress reactivity, low positive affect, high negative affect, chronic pain, and drug craving. This constellation of outcome variables represents a more comprehensive appraisal of the quality of life and quality of recovery than is typically assessed in OUD clinical trials. To date, there are very few clinical trials or experimental studies aimed at improving sleep health in OUD patients, either as a means of improving stress, affect, and craving outcomes, or as a potential mechanistic target to reduce opioid withdrawal and drug use behaviors. As such, the direct impact of sleep improvement in OUD patients is largely unknown, yet mechanistic and clinical research suggests that therapeutic interventions that target sleep are a promising avenue to improve OUD treatment. Public Significance Statement In light of the ongoing opioid crisis, there is a pressing need to improve treatment outcomes for opioid use disorder. Sleep disturbance is a common complaint among persons with opioid use disorder, and interventions that target sleep in this population could improve stress, affect, craving, and/or relapse outcomes.
doi_str_mv 10.1037/pha0000477
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8660927</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2540521158</sourcerecordid><originalsourceid>FETCH-LOGICAL-a443t-661f5a0a2db20e195a8f171f33c2ce2e246b5f3d08f07ae1f3f8bf8c1ff883933</originalsourceid><addsrcrecordid>eNpdkV1rFTEQhhdRbK3e-AMk4I2IW_O12eSmIPWrUCjo6XWYzU56tuxuYrJb6L83h1Nr29wkME-emeGtqreMHjMq2s9xC7Qc2bbPqkNmhKo5N-J5eVMla8ZNe1C9yvmaUiaF4S-rAyEZo1qbw-rX7xExkq9DXtbUweyQQCZANltMEHFdBkc2kK5wIUsgZ1NM4QbJRRzC0JPLjLufIfWYyCYhLBPOy-vqhYcx45u7-6i6_P5tc_qzPr_4cXb65bwGKcVSK8V8AxR433GKzDSgPWuZF8Jxhxy5VF3jRU-1py1gKXjdee2Y91oLI8RRdbL3xrWbsHeldYLRxjRMkG5tgME-rszD1l6FG6uVooa3RfDhTpDCnxXzYqchOxxHmDGs2fJG0oYz1uiCvn-CXoc1zWW9QgnTGKm0KdTHPeVSyDmhvx-GUbuLyv6PqsDvHo5_j_7LpgCf9gBEsDHfOkgljRGzW1MqK-1kVlCrippL8Reu9p8A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2539594689</pqid></control><display><type>article</type><title>Sleep Disturbance as a Therapeutic Target to Improve Opioid Use Disorder Treatment</title><source>MEDLINE</source><source>EBSCOhost APA PsycARTICLES</source><creator>Huhn, Andrew S. ; Finan, Patrick H.</creator><contributor>Stoops, William W</contributor><creatorcontrib>Huhn, Andrew S. ; Finan, Patrick H. ; Stoops, William W</creatorcontrib><description>Sleep health is an important factor across several physical and mental health disorders, and a growing scientific consensus has identified sleep as a critical component of opioid use disorder (OUD), both in the active disease state and during OUD recovery. The goal of this narrative review is to collate the literature on sleep, opioid use, and OUD as a means of identifying therapeutic targets to improve OUD treatment outcomes. Sleep disturbance is common and often severe in persons with OUD, especially during opioid withdrawal, but also in persons on opioid maintenance therapies. There is ample evidence that sleep disturbances including reduced total sleep time, disrupted sleep continuity, and poor sleep quality often accompany negative OUD treatment outcomes. Sleep disturbances are bidirectionally associated with several other factors related to negative treatment outcomes, including chronic stress, stress reactivity, low positive affect, high negative affect, chronic pain, and drug craving. This constellation of outcome variables represents a more comprehensive appraisal of the quality of life and quality of recovery than is typically assessed in OUD clinical trials. To date, there are very few clinical trials or experimental studies aimed at improving sleep health in OUD patients, either as a means of improving stress, affect, and craving outcomes, or as a potential mechanistic target to reduce opioid withdrawal and drug use behaviors. As such, the direct impact of sleep improvement in OUD patients is largely unknown, yet mechanistic and clinical research suggests that therapeutic interventions that target sleep are a promising avenue to improve OUD treatment. Public Significance Statement In light of the ongoing opioid crisis, there is a pressing need to improve treatment outcomes for opioid use disorder. Sleep disturbance is a common complaint among persons with opioid use disorder, and interventions that target sleep in this population could improve stress, affect, craving, and/or relapse outcomes.</description><identifier>ISSN: 1064-1297</identifier><identifier>EISSN: 1936-2293</identifier><identifier>DOI: 10.1037/pha0000477</identifier><identifier>PMID: 34110889</identifier><language>eng</language><publisher>United States: American Psychological Association</publisher><subject>Analgesics, Opioid - therapeutic use ; Craving ; Human ; Humans ; Negative Emotions ; Opiate Substitution Treatment ; Opioid Use Disorder ; Opioid-Related Disorders - drug therapy ; Quality of Life ; Sleep ; Sleep Quality ; Sleep Treatment ; Substance Use Treatment ; Substance Withdrawal Syndrome ; Treatment Outcomes</subject><ispartof>Experimental and clinical psychopharmacology, 2022-12, Vol.30 (6), p.1024-1035</ispartof><rights>2021 American Psychological Association</rights><rights>2021, American Psychological Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a443t-661f5a0a2db20e195a8f171f33c2ce2e246b5f3d08f07ae1f3f8bf8c1ff883933</citedby><orcidid>0000-0002-8073-7701</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34110889$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Stoops, William W</contributor><creatorcontrib>Huhn, Andrew S.</creatorcontrib><creatorcontrib>Finan, Patrick H.</creatorcontrib><title>Sleep Disturbance as a Therapeutic Target to Improve Opioid Use Disorder Treatment</title><title>Experimental and clinical psychopharmacology</title><addtitle>Exp Clin Psychopharmacol</addtitle><description>Sleep health is an important factor across several physical and mental health disorders, and a growing scientific consensus has identified sleep as a critical component of opioid use disorder (OUD), both in the active disease state and during OUD recovery. The goal of this narrative review is to collate the literature on sleep, opioid use, and OUD as a means of identifying therapeutic targets to improve OUD treatment outcomes. Sleep disturbance is common and often severe in persons with OUD, especially during opioid withdrawal, but also in persons on opioid maintenance therapies. There is ample evidence that sleep disturbances including reduced total sleep time, disrupted sleep continuity, and poor sleep quality often accompany negative OUD treatment outcomes. Sleep disturbances are bidirectionally associated with several other factors related to negative treatment outcomes, including chronic stress, stress reactivity, low positive affect, high negative affect, chronic pain, and drug craving. This constellation of outcome variables represents a more comprehensive appraisal of the quality of life and quality of recovery than is typically assessed in OUD clinical trials. To date, there are very few clinical trials or experimental studies aimed at improving sleep health in OUD patients, either as a means of improving stress, affect, and craving outcomes, or as a potential mechanistic target to reduce opioid withdrawal and drug use behaviors. As such, the direct impact of sleep improvement in OUD patients is largely unknown, yet mechanistic and clinical research suggests that therapeutic interventions that target sleep are a promising avenue to improve OUD treatment. Public Significance Statement In light of the ongoing opioid crisis, there is a pressing need to improve treatment outcomes for opioid use disorder. Sleep disturbance is a common complaint among persons with opioid use disorder, and interventions that target sleep in this population could improve stress, affect, craving, and/or relapse outcomes.</description><subject>Analgesics, Opioid - therapeutic use</subject><subject>Craving</subject><subject>Human</subject><subject>Humans</subject><subject>Negative Emotions</subject><subject>Opiate Substitution Treatment</subject><subject>Opioid Use Disorder</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Quality of Life</subject><subject>Sleep</subject><subject>Sleep Quality</subject><subject>Sleep Treatment</subject><subject>Substance Use Treatment</subject><subject>Substance Withdrawal Syndrome</subject><subject>Treatment Outcomes</subject><issn>1064-1297</issn><issn>1936-2293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV1rFTEQhhdRbK3e-AMk4I2IW_O12eSmIPWrUCjo6XWYzU56tuxuYrJb6L83h1Nr29wkME-emeGtqreMHjMq2s9xC7Qc2bbPqkNmhKo5N-J5eVMla8ZNe1C9yvmaUiaF4S-rAyEZo1qbw-rX7xExkq9DXtbUweyQQCZANltMEHFdBkc2kK5wIUsgZ1NM4QbJRRzC0JPLjLufIfWYyCYhLBPOy-vqhYcx45u7-6i6_P5tc_qzPr_4cXb65bwGKcVSK8V8AxR433GKzDSgPWuZF8Jxhxy5VF3jRU-1py1gKXjdee2Y91oLI8RRdbL3xrWbsHeldYLRxjRMkG5tgME-rszD1l6FG6uVooa3RfDhTpDCnxXzYqchOxxHmDGs2fJG0oYz1uiCvn-CXoc1zWW9QgnTGKm0KdTHPeVSyDmhvx-GUbuLyv6PqsDvHo5_j_7LpgCf9gBEsDHfOkgljRGzW1MqK-1kVlCrippL8Reu9p8A</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Huhn, Andrew S.</creator><creator>Finan, Patrick H.</creator><general>American Psychological Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7RZ</scope><scope>PSYQQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8073-7701</orcidid></search><sort><creationdate>20221201</creationdate><title>Sleep Disturbance as a Therapeutic Target to Improve Opioid Use Disorder Treatment</title><author>Huhn, Andrew S. ; Finan, Patrick H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a443t-661f5a0a2db20e195a8f171f33c2ce2e246b5f3d08f07ae1f3f8bf8c1ff883933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analgesics, Opioid - therapeutic use</topic><topic>Craving</topic><topic>Human</topic><topic>Humans</topic><topic>Negative Emotions</topic><topic>Opiate Substitution Treatment</topic><topic>Opioid Use Disorder</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Quality of Life</topic><topic>Sleep</topic><topic>Sleep Quality</topic><topic>Sleep Treatment</topic><topic>Substance Use Treatment</topic><topic>Substance Withdrawal Syndrome</topic><topic>Treatment Outcomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huhn, Andrew S.</creatorcontrib><creatorcontrib>Finan, Patrick H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Access via APA PsycArticles® (ProQuest)</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and clinical psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huhn, Andrew S.</au><au>Finan, Patrick H.</au><au>Stoops, William W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sleep Disturbance as a Therapeutic Target to Improve Opioid Use Disorder Treatment</atitle><jtitle>Experimental and clinical psychopharmacology</jtitle><addtitle>Exp Clin Psychopharmacol</addtitle><date>2022-12-01</date><risdate>2022</risdate><volume>30</volume><issue>6</issue><spage>1024</spage><epage>1035</epage><pages>1024-1035</pages><issn>1064-1297</issn><eissn>1936-2293</eissn><abstract>Sleep health is an important factor across several physical and mental health disorders, and a growing scientific consensus has identified sleep as a critical component of opioid use disorder (OUD), both in the active disease state and during OUD recovery. The goal of this narrative review is to collate the literature on sleep, opioid use, and OUD as a means of identifying therapeutic targets to improve OUD treatment outcomes. Sleep disturbance is common and often severe in persons with OUD, especially during opioid withdrawal, but also in persons on opioid maintenance therapies. There is ample evidence that sleep disturbances including reduced total sleep time, disrupted sleep continuity, and poor sleep quality often accompany negative OUD treatment outcomes. Sleep disturbances are bidirectionally associated with several other factors related to negative treatment outcomes, including chronic stress, stress reactivity, low positive affect, high negative affect, chronic pain, and drug craving. This constellation of outcome variables represents a more comprehensive appraisal of the quality of life and quality of recovery than is typically assessed in OUD clinical trials. To date, there are very few clinical trials or experimental studies aimed at improving sleep health in OUD patients, either as a means of improving stress, affect, and craving outcomes, or as a potential mechanistic target to reduce opioid withdrawal and drug use behaviors. As such, the direct impact of sleep improvement in OUD patients is largely unknown, yet mechanistic and clinical research suggests that therapeutic interventions that target sleep are a promising avenue to improve OUD treatment. Public Significance Statement In light of the ongoing opioid crisis, there is a pressing need to improve treatment outcomes for opioid use disorder. Sleep disturbance is a common complaint among persons with opioid use disorder, and interventions that target sleep in this population could improve stress, affect, craving, and/or relapse outcomes.</abstract><cop>United States</cop><pub>American Psychological Association</pub><pmid>34110889</pmid><doi>10.1037/pha0000477</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-8073-7701</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1064-1297
ispartof Experimental and clinical psychopharmacology, 2022-12, Vol.30 (6), p.1024-1035
issn 1064-1297
1936-2293
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8660927
source MEDLINE; EBSCOhost APA PsycARTICLES
subjects Analgesics, Opioid - therapeutic use
Craving
Human
Humans
Negative Emotions
Opiate Substitution Treatment
Opioid Use Disorder
Opioid-Related Disorders - drug therapy
Quality of Life
Sleep
Sleep Quality
Sleep Treatment
Substance Use Treatment
Substance Withdrawal Syndrome
Treatment Outcomes
title Sleep Disturbance as a Therapeutic Target to Improve Opioid Use Disorder Treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T17%3A57%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sleep%20Disturbance%20as%20a%20Therapeutic%20Target%20to%20Improve%20Opioid%20Use%20Disorder%20Treatment&rft.jtitle=Experimental%20and%20clinical%20psychopharmacology&rft.au=Huhn,%20Andrew%20S.&rft.date=2022-12-01&rft.volume=30&rft.issue=6&rft.spage=1024&rft.epage=1035&rft.pages=1024-1035&rft.issn=1064-1297&rft.eissn=1936-2293&rft_id=info:doi/10.1037/pha0000477&rft_dat=%3Cproquest_pubme%3E2540521158%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2539594689&rft_id=info:pmid/34110889&rfr_iscdi=true